| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.00076 | 1 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.00075 | 1 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |